Infections due to zygomycetes and other rare fungal opportunists

Seminars in Respiratory and Critical Care Medicine

Volumn 18, Issue 3, 1997, Pages 265-279

  Alspaugh, J Andrew ^a   Perfect, John R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Fusariosis; Trichosporonosis; Zygomycosis

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; COTRIMOXAZOLE; FLUCYTOSINE; ITRACONAZOLE;

ACREMONIUM; CLINICAL FEATURE; CONFERENCE PAPER; FUSARIUM; HUMAN; HYPHOMYCETES; MUCORMYCOSIS; MYCOSIS; OPPORTUNISTIC INFECTION; PATHOPHYSIOLOGY; PENICILLIUM MARNEFFEI; PHAEOHYPHOMYCOSIS; PRIORITY JOURNAL; TRICHOSPORON BEIGELII; ZYGOMYCETES;

EID: 0030809250     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1070996     Document Type: Conference Paper

References (67)

1. Perfect JR, Schell WA. The new fungal opportunists are coming. Clin Infect Dis 1996;22(Suppl 2)-S112-18
2. Lehrer RI (Moderator) Mucormycosis. Ann Intern Med 1980;93:93-108
3. McGinnis MR, Ajello L, Schell WA. Mycotic diseases: a proposed nomenclature. Int J Dermatol 1985;24:9-15
4. Kwon-Chung KJ, Bennett JE. Medical Mycology. Philadelphia, Lea and Febiger, 1992;524-59
5. Sugar AM. Mucormycosis. Clin Infect Dis 1992;14(Suppl 1):S126-9
6. Schwartz J. The diagnosis of deep mycoses by morphologic methods. Hum Pathol 1982;13:519-33
7. Walsh TJ, Renshaw G, Andrews J, et al. Invasive zygomycosis due to Conidiobolus incongruus. Clin Infect Dis 1994;19: 423-30
8. Waldorf AR, Ruderman N, Diamond RD. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus. J Clin Invest 1984;74:150-60
9. Waldorf AR, Levitz SM, Diamond RD In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J Infect Dis 1984;150:752-60
10. Rex JH, Ginsberg AM, Fries LF, Pass HI, Kwon-Chung KJ. Cunninghamella bertholletiae infection associated with deferoxamine therapy. Rev Infect Dis 1988;10:1187-94
11. Artis WM, Fountain JA, Delcher HK, Jones HE. A mechanism of susceptibilty to mucormycosis in diabetic ketoacidosis: transferrin and iron availability. Diabetes 1982;31:1109-14
12. Tedder M, Spratt JA, Anstadt MP, Hegde SS, Tedder SD, Lowe JE. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg 1994;57:1044-50
13. Rothstein RD, Simon GL. Subacute pulmonary mucormycosis. J Med Vet Mycol 1986;24:391-4
14. Bragg DG, Janis B. The roentgenologic manifestations of pulmonary opportunistic infections. Am J Roentgenol Radium Ther Nucl Med 1973;117:798-809
15. Wanishawad C, Kimbrough RC, Chinratanalab S, Nugent K. Mucormycotic osteolytic rib lesion presenting as subacute pleural effusion. Clin Infect Dis 1996;22:715-16
16. Potente G. CT findings in fungal opportunistic pneumonias: body and brain involvement, Comp Med Imag Graph 1989;13:423-8
17. Radner AB, Witt MD, Edwards Jr JE. Acute invasive rhinocerebral zygomycosis in an otherwise healthy patient: case report and review. Clin Infect Dis 1995;20:163-6
18. Yohai RA, Bullock JD, Aziz AA, Markett RJ. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol 1994;39:3-22
19. Hopkins RJ, Rothman M, Fiore A, Goldblum SE. Cerebral mucormycosis associated with intravenous drug use: three case reports and review Clin Infect Dis 1994;21:1133-7
20. Agha FP, Lee HH, Boland CR, Bradley SF. Mucormycoma of the colon: early diagnosis and successful management. Am J Roentgenol 1985;145:739-41
21. Oliver MR, Van Voorhis WC, Boeckh M, Mattson D, Bowden RA. Hepatic mucormycosis in a bone marrow transplant recipient who ingested naturopathic medicine. Clin Infect Dis 1996;22:521-4
22. Adam RD, Hunter G, DiTomasso J, Comerci Jr G. Mucormycosis: emerging prominence of cutaneous infections. Clin Infect Dis 1994;19(1):67-76
23. Gartenberg G, Bottone EJ, Kensch GT, Weitzman I. Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue: epidemiology, mycology and treatment. N Engl J Med 1978;299:1115-18
24. Okhuysen PB, Rex JH, Kapusta M, Fife C. Successful treatment of extensive posttraumatic soft-tissue and renal infections due to Apophysomyces elegans. Clin Infect Dis 1994; 19:329-31
25. Weinberg WG, Wade BH, Cierny III G, Stacy D, Rinaldi MG. Invasive infection due to Apophysomyces elegans in immunocompetent hosts. Clin Infect Dis 1993;17(5):881-4
26. Paparello SF, Parry RL, MacGillivray DC, Brock N, Mayers DL. Hospital-acquired wound mucormycosis. Clin Infect Dis 1992;14(1):350-2
27. Ingram CW, Sennesh J, Cooper JN, Perfect JR. Disseminated zygomycosis: report of four cases and review. Rev Infect Dis 1989;11(5):741-54
28. Sane A, Manzi S, Moore J, Perfect JR. Deferoxamine treatment as a risk factor for zygomycete infection. J Infect Dis 1989;159:151-2
29. Hibberd PL, Rubin RH. Clinical aspects of fungal infection in organ transplant recipients. Clin Infect Dis 1994; 19(Suppl 1):S33-40
30. Singh N, Gayowski T, Singh J, Yu VL. Invasive gastrointestinal zygomycosis in a liver transplant recipient, case report and review of zygomycosis in solid-organ transplant recipients. Clin Infect Dis 1995;20:617-20
31. Nagy-Agren SE, Chu P, Smith GJ, Waskin HA, Altice FL. Zygomycosis (mucormycosis) and HIV infection: report of three cases and review. J Acquir Immun Defic Syndr Hum Retrovirol 1995;10:441-9
32. Ferguson BJ, Mitchell TG, Moon R, Camporesi EM, Farmer J. Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis. Rev Infect Dis 1988;10: 551-9
33. Al-Hajjar S, Perfect JR, Hashem F, Tufenkeji H, Kayes S. Orbito-fascial conidiobolomycosis in a child. Pediatr Infect Dis J
34. Strasser MD, Kennedy RJ, Adam RD. Rhinocerebral mucormycosis. Therapy with amphotericin B lipid complex. Arch Intern Med 1996;156:337-9
35. Lim KK, Potts MJ, Warnock DW, Ibrahim NB, Brown EM, Burns-Cox CJ. Another case report of rhinocerebral mucormycosis treated with liposomal amphotericin B and surgery. Clin Infect Dis 1994;18:653-4
36. Gonzalez CE, Couriel DR, Walsh TJ. Disseminated zygomycosis in a neutropenic patient: successful treatment with amphotericin B lipid complex and granulocyte colony-stimulating factor. Clin Infect Dis 1997;24:192-6
37. Nahass GT, Rosenberg SP, Leonard CL, Penneys NS. Disseminated infection with Trichosporon beigelii. Report of a case and review of the cutaneous and histologic manifestations. Arch Dermatol 1993;129:1020-3
38. Tashiro T, Nagai H, Nagaoka H, Goto Y, Kamberi P, Nasu M. Trichosporon beigelii pneumonia in patients with hematologic malignancies. Chest 1995;108:190-5
39. Walsh TJ, Lee JW, Melcher GP, et al. Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis. J Infect Dis 1992;166:121-33
40. Walsh TJ. Trichosporonosis. Infect Dis Clin North Am 1989;3:43-52
41. Barcchiesi F, Morboducci V, Ancarani F, Arzeni D, Scalise G. Trichosporon beigelii fungaemia in an AIDS patient. AIDS 1993;7:139-40
42. Hussain Quadri SM, Ellis ME. Localized pulmonary disease due to Trichosporon beigelii. J Natl Med Assoc 1992;84: 449-52
43. Anaissie EJ, Hachem R, Karyotakis NC, et al. Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis. Antimicrob Agents Chemother 1994;38:2541-4
44. Anaissie E, Gokaslan A, Hachem R, et al. Azole therapy of trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review. Clin Infect Dis 1992;15:781-7
45. Melez KA, Cherry J, Sanchez C, Ettinger RB, Walsh TJ. Successful outpatient treatment of Trichosporon beigelii peritonitis with oral fluconazole. Pediatr Infect Dis J 1995; 14:1110-13
46. Fothergill AW. Identification of dematiaceous fungi and their role in human disease. Clin Infect Dis 1996;22(Suppl 2):S179-84
47. McGinnis MR. Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology. J Am Acad Dermatol 1983;8:1-16
48. Matsumoto T, Ajello L, Matsuda T, Szaniszlo PJ, Walsh TJ. Developments in hyalohyphomycosis and phaeohyphomycosis. J Med Vet Mycol 1994;32(Suppl 1):329-49
49. Fader CF, McGinnis MR. Infections caused by dematiaceous fungi: chromoblastomycosis and phaeohyphomycosis. Infect Dis Clin North A III 1988;2:925-39
50. Schell WA, Perfect JR. Subcutaneous infections by dematiaceous fungi. Clin Adv Treat Fungal Infect 1992;3:6-14
51. Dixon DM, Walsh TJ, Merz WG, McGinnis MR. Infections due to Xylohypha bantiana (Cladosporium trichoides). Rev Infect Dis 1987;11:515-25
52. Singh N, Chang FY, Gayowski T, Marino IR. Infections due to dematiaceous fungi in organ transplant recipients: case report and review. Clin Infect Dis 1997;24:369-74
53. Morris A, Schell WA, McDonaugh D, Chaffee S, Perfect JR. Fonsecaea pedrosoi pneumonia and Emericella nidulans cerebral abscesses in a bone marrow transplant patient. Clin Infect Dis 1995;21:1346-8
54. Wood GM, McCormack JG, Muir DB, et al. Clinical features of human infection with Scedosporium inflatum. Clin Infect Dis 1992;14:1027-33
55. Kwon-Chung KJ, Bennett JE. Medical Mycology. Philadelphia, Lea and Febiger, 1992;743-4
56. Schell WA. New aspects of emerging fungal pathogens: a multifaceted challenge. Clin Lab Med 1995;15:365-87
57. Vartvarian SE, Annaissie EJ, Bodey GP. Emerging fungal pathogens in immunocomprormised patients: classification, diagnosis, and management. Clin Infect Dis 1993; 17(Suppl 2):S487-91
58. Nelson PE, Dignani MC, Annaissie EJ. Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev 1994;7:479-504
59. Arrese JE, Pierard-Franchimont C, Pierard GE. Fatal hyalohyphomycosis following Fusarium onychomycosis in an immunocompromised patient. Am J Dermatopathol 1996;18:196-8
60. Zach TL, Penn RG, Gnarra DJ, BeverJL. Fusarium moniliforme pneumonia. Nebr Med J 1987;1987:6-9
61. Kwon-Chung KJ, Bennett JE. Medical Mycology. Philadelphia, Lea and Febiger, 1992;744-5
62. Noble RC, Salgado J, Newell SW, Goodman NL. Endophthalmitis and lumbar diskitis due to Acremonium falciforme in a splenectomized patient. Clin Infect Dis 1997;24:277-8
63. Kwon-Chung KJ, Bennett JE. Medical Mycology. Philadelphia, Lea and Febiger, 1992;747-50
64. Supparatpinyo K, Chiewchanvit S, Hirunsri P, Uthammachai C, Nelson KE, Sirisanthana T. Penicillium marneffei infection in patients infected with human immunodeficiency virus. Clin Infect Dis 1992;14:871-4
65. Jones PD, See J. Penicillium marneffei infection in patients infected with human immunodeficiency virus: late presentation in an area of nonendemicity. Clin Infect Dis 1992;15: 744
66. Sekhon AS, Stein L, Garg AK, Black WA, Glezos JD, Wong C. Pulmonary penicillosis marneffei: report of the first imported case in Canada. Mycopathologia 1994;128:3-7
67. Supparatpinyo K, Nelson KE, Merz WG, et al. Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens. Antimicrob Agents Chemother 1993;37: 2407-11